Cargando…
Serum IgG4 level predicts COVID-19 related mortality
Autores principales: | Della-Torre, Emanuel, Lanzillotta, Marco, Strollo, Marta, Ramirez, Giuseppe Alvise, Dagna, Lorenzo, Tresoldi, Moreno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461218/ https://www.ncbi.nlm.nih.gov/pubmed/34598853 http://dx.doi.org/10.1016/j.ejim.2021.09.012 |
Ejemplares similares
-
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply
por: Della-Torre, Emanuel, et al.
Publicado: (2022) -
Treating COVID-19 with colchicine in community healthcare setting
por: Della-Torre, Emanuel, et al.
Publicado: (2020) -
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse
por: Lanzillotta, Marco, et al.
Publicado: (2018) -
IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian Patients
por: Rampi, Andrea, et al.
Publicado: (2020) -
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)